Overview and Mechanism of Action

Acetazolamide sodium is the sodium salt form of acetazolamide, a sulfonamide-derived carbonic anhydrase (CA) inhibitor. By blocking carbonic anhydrase isoforms (notably CA II and CA IV), it prevents the reversible hydration of carbon dioxide to bicarbonate and a proton (CO₂ + H₂O ⇌ HCO₃⁻ + H⁺). This inhibition disrupts bicarbonate transport across epithelial membranes in the kidney, eye, and choroid plexus, resulting in reduced aqueous humor production, diuresis, and altered cerebrospinal fluid dynamics.

In research contexts, acetazolamide sodium is used as a pharmacological tool to:

• Induce metabolic acidosis models in cell culture and animal studies
• Investigate intraocular pressure regulation and glaucoma pathophysiology
• Model acute mountain sickness and hypoxic ventilatory response
• Study renal tubular function and bicarbonate reabsorption mechanisms

The sodium salt formulation confers superior aqueous solubility compared to the free acid form, facilitating direct preparation of stock solutions in aqueous buffers without organic co-solvents.

Solution Preparation Protocol

Recommended solvents and stock solution preparation:

1. Aqueous stock solution: Dissolve acetazolamide sodium in sterile ultrapure water or phosphate-buffered saline (PBS, pH 7.4) to a stock concentration of 10–50 mM. Vortex gently until fully dissolved. The sodium salt form dissolves readily without heating.
2. Concentration verification: Verify stock concentration spectrophotometrically if required by your assay. Record the exact concentration and preparation date on the storage vial.
3. Filtration: For cell culture applications, sterile-filter the stock solution through a 0.22 µm membrane filter under aseptic conditions.
4. Working solution: Dilute stock solution to the desired working concentration in the appropriate assay buffer or cell culture medium immediately before use. Typical in vitro working concentrations range from 10 µM to 1 mM depending on the experimental model; consult primary literature for your specific application.
5. pH check: After dilution into culture medium, verify that the final pH remains within the acceptable range for your cell line (typically 7.2–7.6). High concentrations of acetazolamide sodium may affect medium buffering capacity.

Note: Avoid preparing solutions in DMSO or ethanol unless aqueous solubility is demonstrably insufficient for your application, as the sodium salt form has excellent water solubility. If organic solvents are required for comparative experiments, ensure vehicle controls are included.

Storage, Stability, and Quality Control

Bulk powder: Store the as-supplied solid at −20 °C in a tightly sealed container, protected from light and atmospheric moisture. Under these conditions, the compound is expected to be stable for at least 24 months from the date of manufacture; refer to the Certificate of Analysis (CoA) for the specific expiry date of your lot.

Stock solutions: Aqueous stock solutions should be prepared fresh where possible. If storage is required, aliquot into single-use volumes to avoid repeated freeze-thaw cycles, store at −20 °C, and use within 1–3 months. Avoid storing dilute aqueous solutions at 4 °C for extended periods as hydrolytic degradation may occur.

Quality control checks:

• Confirm compound identity and purity from the supplied CoA (typically assessed by HPLC and NMR or MS).
• Visually inspect powder before weighing: the compound should appear as a white to off-white solid. Discard if discoloration or clumping is observed and contact Aladdin Scientific for replacement.
• For critical experiments, verify biological activity using a known positive-control assay (e.g., CA enzyme inhibition assay) alongside experimental samples.

Safety and Regulatory Considerations

Acetazolamide sodium is supplied for research use only (RUO) and is not intended for human or veterinary therapeutic use. Researchers should consult the Safety Data Sheet (SDS) provided by Aladdin Scientific before handling.

General precautions:

• Wear appropriate personal protective equipment (PPE): laboratory coat, chemical-resistant gloves, and eye protection when handling powder or concentrated solutions.
• Avoid inhalation of dust when weighing. Conduct powder handling in a fume hood or with respiratory protection where dust generation is possible.
• Sulfonamide derivatives may cause sensitization in susceptible individuals; personnel with known sulfonamide hypersensitivity should exercise caution or designate an alternative handler.
• Dispose of waste solutions and contaminated materials in accordance with local institutional and governmental regulations for chemical waste.

First aid (general guidance; refer to full SDS for authoritative information):

• Skin contact: Wash thoroughly with soap and water.
• Eye contact: Rinse immediately with copious water for at least 15 minutes and seek medical advice.
• Inhalation: Move to fresh air; seek medical attention if symptoms persist.